Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-23T17:57:52.292Z Has data issue: false hasContentIssue false
  • English
  • Français

New methods in brain imaging1

Published online by Cambridge University Press:  09 July 2009

Sigrid Herold  and
Richard J. Frackowiak
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Psychological Medicine , Volume 16 , Issue 2 , May 1986 , pp. 241 - 245
Copyright
Copyright © Cambridge University Press 1986

References

Albert, M., Naeser, M. A., Levine, H. L. & Garvey, A. J. (1984). CT density numbers in patients with senile dementia of the Alzheimer type. Archives of Neurology 41, 1264–1269.CrossRefGoogle Scholar
Baron, J. C., Maziere, B., Loch, C., Sgouropoulos, P., Bonnet, A. M. & Agid, Y. (1985). Progressive supranuclear palsy: loss of striatal dopamine receptors demonstrated in vivo. Lancet i, 1163–1164.CrossRefGoogle Scholar
Baxter, L. R., Phelps, M. E., Mazziotta, J. C., Schwartz, J. M., Gerner, R. H., Selin, C. E. & Sumida, R. M. (1985). Cerebral metabolic rates for glucose in mood disorders: studies with positron emission tomography and fluorodeoxyglucose F18. Archives of General Psychiatry 42, 441–447.CrossRefGoogle Scholar
Beaney, R. P. (1984). Positron emission tomography in the study of human tumors. Seminars in Nuclear Medicine 14, 324–341.CrossRefGoogle Scholar
Benson, D. F., Kuhl, D. E., Hawkins, R. A., Phelps, M. E., Cummings, J. L. & Tsai, S. Y. (1983). The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Archives of Neurology 40, 711–714.CrossRefGoogle ScholarPubMed
Besson, J. A. O., Glen, A. I. M., Foreman, E. I., MacDonald, A., Smith, F. W., Hutchison, J. M. S., Mallard, J. R. & Ashcroft, G. W. (1981). Nuclear magnetic resonance observations in alcoholic cerebral disorder and the role of vasopressin. Lancet ii, 923–924.Google Scholar
Besson, J. A. O., Corrigan, F. M., Foreman, E. I., Eastwood, L. M., Smith, F. W. & Ashcroft, G. W. (1985). Nuclear magnetic resonance (NMR) II. Imaging in dementia. British Journal of Psychiatry 146, 31–35.CrossRefGoogle ScholarPubMed
Brodie, J. D., Christman, D. R., Corona, J. F., Fowler, J. S., Gomez-Mont, F., Jaeger, J., Micheels, P. A., Rotrosen, J., Russell, J. A., Volkow, N. D., Wikler, A., Wolf, A. P. & Wolkins, A. (1984). Patterns of metabolic activity in the treatment of schizophrenia. Annals of Neurology 15 (Suppl.), S166–S169.CrossRefGoogle ScholarPubMed
Buchsbaum, M. S., Ingvar, D. H., Kessler, R., Waters, R. N., Cappelletti, J., van Kammen, D. P., King, A. C., Johnson, J. L., Manning, A. G., Plynn, R. W., Mann, L. S., Bunney, W. E. & Sokoloff, L. (1982). Cerebral glucography with positron tomography. Archives of General Psychiatry 39, 251–259.CrossRefGoogle ScholarPubMed
Buchsbaum, M. S., De Lisi, L. E., Holcomb, H. H., Cappelletti, J., King, A. L., Johnson, J., Hazlett, E., Dowling-Zimmerman, S., Post, R. M., Morihisa, J., Carpenter, W., Cohen, R., Pickar, D., Weinberger, D. R., Margolin, R. & Kessler, R. H. (1984). Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Archives of General Psychiatry 71, 1159–1166.CrossRefGoogle Scholar
Bustany, P., Henry, J. F., De Roton, J., Signoret, P., Cabanis, E., Zarifian, E., Ziegler, M., Derlon, M., Crousel, C., Soussaline, F. & Comar, D. (1985). Correlations between clinical state and positron emission tomography measurements of local brain protein synthesis, in Alzheimer's dementia, Parkinson's disease, schizophrenia, and gliomas. In The Metabolism of the Human Brain Studied with Positron Emission Tomography (ed. Greitz, T., Ingvar, D. H. and Widen, L.), pp. 241–249. Raven Press: New York.Google Scholar
Clark, C. M., Kessler, R., Buchsbaum, M. S., Margolin, R. A. & Holcomb, H. H. (1984). Correlational methods for determining regional coupling of cerebral glucose metabolism: pilot study. Biological Psychiatry 19, 663–678.Google ScholarPubMed
Comar, D., Maziere, M., Gadot, J. M., Berger, G. & Soussaline, F. (1979). visualisation of 11C-flunitrazepam displacement in the brain of the live baboon. Nature 280, 329–331.CrossRefGoogle ScholarPubMed
Di Chiro, G., De La Paz, K., Smith, B., Kornblith, P., Sokoloff, L., Brooks, R., Blasberg, C., Cummins, C., Kessler, R., Wolf, A., Fowler, J., London, W. & Sever, J. (1981). 18F-2-fluoro-2-deoxyglucose position emission tomography of human cerebral gliomas. Journal of Computer Assisted Tomography 5, 937–938.CrossRefGoogle Scholar
De Lisi, L. E., Holcomb, H. H., Cohen, R. M., Picker, D., Carpenter, W., Morilisa, J. M., King, A. C., Kessler, R. & Buchsbaum, M. S. (1985). Positron emission tomography in schizophrenic patients with and without neuroleptic medication. Journal of Cerebral Blood Flow and Metabolism 5, 201–206.CrossRefGoogle ScholarPubMed
Farde, L., Ehrin, E., Eriksson, L., Greitz, T., Hall, H. & Sedvall, G. (1985). 11-C-labelled dopamine-D2 receptor antagonists as tools for quantitative studies on dopamine receptors in the human brain. Journal of Cerebral Blood Flow and Metabolism 5 (Suppl. 1), S595–596.Google Scholar
Farde, L., Hall, H., Ehrin, E. & Sedvall, G. (1986). Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231, 258–261.CrossRefGoogle ScholarPubMed
Farkas, T., Wolf, A. P., Jaeger, J., Brodie, J., Christman, D. R. & Fowler, J. S. (1984). Regional brain glucose metabolism in chronic schizophrenia. Archives of General Psychiatry 41, 293–300.CrossRefGoogle ScholarPubMed
Frackowiak, R. S. J., Pozzilli, C., Legg, N. J., DuBoulay, G. H., Marshall, J., Lenzi, G. L. & Jones, T. (1981). Regional cerebral oxygen supply and utilisation in dementia: a clinical and physiological study with oxygen-15 and positron tomography. Brain 104, 753–778.CrossRefGoogle ScholarPubMed
Frost, J. J., Wagner, H. N., Dannals, R. F., Ravert, H. T., Links, J. M., Wilson, A. A., Burns, H. D., Wong, D. F., McPherson, R. W., Rosenbaum, A. E., Kuhar, M. J. & Snyder, S. H. (1985). Imaging opiate receptors in the human brain by positron tomography. Journal of Computer Assisted Tomography 9, 231–236.CrossRefGoogle ScholarPubMed
Garnett, E. S.Firnau, G. & Nahmias, C. (1983). Dopamine visualised in the basal ganglia of living man. Nature 305, 137–138.CrossRefGoogle ScholarPubMed
Herold, S., Frackowiak, R. S. J., Rutter, M. & Howlin, P. (1985 a). Regional cerebral blood flow, oxygen metabolism and glucose metabolism in young autistic adults. Journal of Cerebral Blood Flow and Metabolism 5 (Suppl. 1), S189–190.Google Scholar
Herold, S., Leenders, K. L., Turton, D. R., Kensett, J. M., Pike, V. W., Clark, J. C., Brooks, D. J., Crow, T. J., Owen, F., Cooper, S. & Johnstone, E. C. (1985). Dopamine receptor binding in schizophrenic patients as measured with 11C-methylspiperone and PET. Journal of Cerebral Blood Flow and Metabolism 5 (Suppl. 1), S191–192.Google Scholar
Hilal, S. K., Maudsley, A. A., Ra, G. B., Simon, H. E., Roschmann, P., Wittekoek, S., Cho, Z. H. & Mum, S. K. (1985). In vito NMR imaging of sodium-23 in the human head. Journal of Computer Assisted Tomography 9, 1–7.CrossRefGoogle Scholar
Hope, P. L., Costello, A. M. del, Cady, E. B., Delpy, D. T., Tofts, P. S., Chu, A., Hamilton, P. A.Reynolds, E. O. R. & Wilkie, D. R. (1984). Cerebral energy metabolism studied with phosphorus NMR spectroscopy in normal and birth-asphyxiated infants. Lancet ii, 366–370.CrossRefGoogle Scholar
Ingvar, D. H. & Franzen, G. (1974). Distribution of cerebral activity in schizophrenia. Lancet ii, 1484–1486.CrossRefGoogle Scholar
Jones, A. K. P., Luthra, S. K., Pike, V. W., Herold, S. & Brady, F. (1985). New labelled ligand for in-vivo studies of opioid physiology. Lancet ii, 665–666.CrossRefGoogle Scholar
Kuhl, D. E., Phelps, M. E., Markham, C. H., Metter, E. J., Riege, W. H. & Winter, J. (1982). Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Annals of Neurology 12, 425–434.CrossRefGoogle ScholarPubMed
Leenders, K. L., Herold, S., Brooks, D. J., Palmer, A. J., Turton, D., Firnau, G., Garnett, E. S., Nahmias, C. & Veall, N. (1984). Presynaptic and postsynaptic dopaminergic system in human brain. Lancet ii, 110–111.CrossRefGoogle Scholar
Leenders, K. L., Herold, S., Palmer, A. J., Turton, D., Quinn, N., Jones, T., Frackowiak, R. S. J. & Marsden, C. D. (1985). Human cerebral dopamine system measured in vivo using PET. Journal of Cerebral Blood Flow and Metabolism 5 (Suppl. 1), S157–158.Google Scholar
Naeser, M. A., Gebhardt, C. & Levine, H. L. (1980). Decreased computerised tomography numbers in patients with presenile dementia: detection in patients with otherwise normal scans. Archives of Neurology 37, 401–409.CrossRefGoogle ScholarPubMed
Powers, W. J. & Raichle, M. E. (1985). Positron emission tomography and its application to the study of cerebrovascular disease in man. Stroke 16, 361–376.CrossRefGoogle Scholar
Radda, G. K., Bore, P. J. & Rajagopalan, B. (1984). Clinical aspects of 31P NMR spectroscopy. British Medical Bulletin 40, 155–159.CrossRefGoogle ScholarPubMed
Reveley, M. A. (1985). CT scans in schizophrenia. British Journal of Psychiatry 146, 367–371.CrossRefGoogle ScholarPubMed
Rumsey, J. M., Duara, R., Grady, C., Rapoport, J. L., Margolin, R. A., Rapoport, S. I. & Cutler, N. R. (1985). Brain metabolism in autism. Archives of General Psychiatry 42, 448–455.CrossRefGoogle ScholarPubMed
Sheppard, G., Gruzelier, J., Manchanda, R., Hirsch, S. R., Wise, R., Frackowiak, R. & Jones, T. (1983). 15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients. Lancet ii, 1148–1152.Google Scholar
Wagner, H. N., Burns, D. H., Dannals, R. F., Wong, D. F., Langstrom, B., Duelfero, T., Frost, J. J., Ravert, H. T., Links, J. M., Rosenbloom, S. B., Lukas, S. E., Kramer, A. V. & Kuhar, M. J. (1983). Imaging dopamine receptors in the brain by positron tomography. Science 22, 1264–1266.CrossRefGoogle Scholar
Widen, L., Bergstrom, M., Blomqvist, G., Brimar, T., Ehrin, E., Elander, S., Eriksson, K., Eriksson, L., Greitz, T., Litton, J.-E., Malmborg, P., Wilsson, L., Sedvall, G. & Ugglas, M. (1981). Glucose metabolism in patients with schizophrenia: emission computed tomography measurements with 11-C-Glucose. Journal of Cerebral Blood Flow and Metabolism 1 Suppl. 1, S455–S456.Google Scholar
Widen, L., Blomqvist, G., Greitz, T., Litton, J. E., Bergstrom, M., Ehrin, E., Ericson, K., Eriksson, L., Ingvar, D. H., Johansson, L., Nilsson, J. L. G., Stone-Elander, S., Sedvall, G., Wiesel, F. & Wiik, G. (1983). PET studies of glucose metabolism in patients with schizophrenia. American Journal of Neuroradiology 4, 550–552.Google ScholarPubMed
Wiesel, F. A., Blomqvist, G., Ehrin, E., Greitz, T., Ingvar, D. H., Litten, J., Nilsson, L., Sedvall, G., Stone-Elander, S., Widen, L. & Wiik, G. (1985). Brain energy metabolism in schizophrenia studied with 11C-glucose. In The Metabolism of the Human Brain Studied with Positron Emission Tomography (ed. Greitz, T., lngvar, D. H. and Widen, L.), pp. 485–493. Raven Press: New York.Google Scholar
Young, I. R., Hall, A. S., Pallis, C. A., Bydder, G. M., Legg, N. J. & Steiner, R. E. (1981). Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet ii, 1063–1066.CrossRefGoogle Scholar